Although the biotechnology industry has slowed down since the COVID-19 pandemic, there is a 13.96% expected CAGR of the market from 2023 to 2030 according to Grand View Research. As new technologies are developed and new solutions to the health challenges facing the world are developed, the scope of the biotechnology market continues to expand.
Major Trends in Bioprocessing for 2023
Cell & Gene Therapy
Many companies and organizations entered the cell and gene therapy space within the past year, earning over $23 billion in 2023, which is up 16% from 2022 according to NASDAQ. These therapies aim to target health complications created by variations in a person's cellular and genetic makeup.
High Purity New England (HPNE), a leading manufacturer of biopharma and biotech solutions has a wide range of products to aid companies looking to make new cell and gene therapy products and discoveries. Their flagship HPConnexx™ Single-Use Assemblies can be created to meet your specific needs throughout the cell and gene therapy drug creation process, from discovery to fill-finish. With no minimum order and fast lead times, these single-use assemblies can help you get your products to the people who need them, when they need them.
Additionally, their FlowMaxx Pro 30 Quaternary Diaphragm Pumps can integrate both flow and pressure sensors, and can accommodate a flow range of 1 mL/min to 500 mL/min. Also available is their MicroMaxx Lab-Scale Screening System, created to eliminate tedious work in your lab space by automating your hollow fiber screening process, giving you more time to develop life saving therapies.
The first step to creating effective cell and gene therapy solutions is having the best equipment for the job, and HPNE is confident that they can provide the perfect solution for your bioprocess.
The drug discovery market had an estimated value of $60.29 billion in 2023, with an expected CAGR of 9.2% from 2023 to 2032. North America region was the largest market within the drug discovery industry. The evolving technology of the biopharma and biotech markets has expedited the drug discovery process to a rate we have not previously seen.
With years of drug discovery expertise, High Purity New England is able to deliver trustworthy developments that you can count on to advance your drug discovery processes. As mentioned above for cell and gene therapy, their HPConnexx Single-Use Assemblies can be customized to your specific needs, meaning they can also be created for your drug discovery process. Reach out to their expert team at [email protected] to start the process of creating your perfect assembly.
For your adherent cell expansion needs, in 2023 HPNE introduced their new product, the CellScrew® from Green Elephant Biotech. This product is a sustainable solution for drug discovery, made with 90% less plastic waste and CO2 emissions compared to other multilayer flasks. Constructed with plant-based PLA plastic, the CellScrew® also has applications in vaccine manufacturing and drug screening.
Optimize Your Systems in 2024
As you continue your day-to-day operations in 2024, it can be helpful to reflect on your current processes. Is your company or organization prepared to spearhead cell and gene therapies and other drug discoveries in the new year?
With a variety of technological advances ready to enhance your bioprocess, now is the time to upgrade your equipment and get ahead of the industry trends that are expected to see major growth in the coming years.